OmniSeq News

OmniSeq Names Dr. Shengle Zhang as New Lab Director

FOR IMMEDIATE RELEASE MEDIA CONTACT: Sawyer Lipari Lambert & Co. 313.309.9551 OmniSeq Names Dr. Shengle Zhang as New Lab Director Fast-growing cancer diagnostic laboratory continues focus on development of innovative product breakthroughs...

Schoenborn named CEO at OmniSeq

June 26, 2019 Buffalo News - OmniSeq Inc., a molecular diagnostic laboratory on the Buffalo Niagara Medical Campus, has a new CEO. Margot P. Schoenborn, formerly the company's chief administrative officer, has been promoted to the position.

People in the News

June 26, 2019 GenomeWeb - OmniSeq announced today that it has appointed Margot Schoenborn to succeed Mark Gardner as the firm's CEO.

Margot Schoenborn becomes CEO of fast-growing OmniSeq

Business First - Margot Schoenborn has quite the resume. Now she gets to add yet another interesting professional experience: biotech boss. Schoenborn has been named the CEO of OmniSeq, which develops and sells molecular diagnostic tests that show cancer patients what...

OmniSeq & LabCorp Launch OmniSeq Advance℠ Assay

New test combines both targeted therapy and immune-oncology biomarkers in a single test with 99% actionability, providing benefits for the treatment of patients and the development of new therapies.ASCO, CHICAGO, ILLINOIS – June 1, 2018 – OmniSeq® , a CAP accredited,...

Follow Us on Twitter

Congrats to @OmniSeq's Jeffrey Conroy and @PablaSabi on their contribution to the TMB Harmonization Consortium's study aimed at facilitating harmonization and alignment across tissue TMB assays.

Watch “Labcorp Oncology Capabilities Across the Continuum of Care.mp4” on #Vimeo

Congratulations to @OmniSeq’s R.J. Seager, Y. Lee, J. Conroy and S. Pabla on the great work with @RoswellPark's S. Mukherjee on their #ESMO21 abstract 1472P, “Cancer/testis antigen expression landscape in gastroesophageal adenocarcinoma”

Congratulations to @OmniSeq's Sarabjot Pabla, Mary Nesline, Sean Glenn, Jeffrey Conroy, Paul DePietro on their #ESMO21 abstract 992P “Diverse RNA expression patterns of T cell priming markers in various solid tumors and their clinical implication”

TY @OmniSeq for your commitment to helping people w/cancer find the right treatment path. Shining a light on #lungcancer is important & appreciated. #biomarker testing saves lives! Your voice and hard work is critical! #anyonewithlungscangetlungcancer #researchmatters @TheWRP4LC


Advancing lung cancer awareness and changing the public perception of the disease is the commitment of @TheWRP4LC. Anyone with lungs can get lung cancer. Sharing their mission and goals, @OmniSeq is extremely proud to receive a White Ribbon from this amazing organization!

Load More...